Drug Type Small molecule drug |
Synonyms NTRC 0066-0, NTRC00660 |
Target |
Action inhibitors |
Mechanism TTK inhibitors(Dual specificity protein kinase TTK inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC33H39N7O2 |
InChIKeyHGEIUFJVGHMGRR-UHFFFAOYSA-N |
CAS Registry1817791-73-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Triple Negative Breast Cancer | Preclinical | Netherlands | 01 Oct 2015 | |
Triple Negative Breast Cancer | Preclinical | Netherlands | 01 Oct 2015 |